Skip to main content
Premium Trial:

Request an Annual Quote

Do Something

In a report addressed to the US National Institutes of Health Advisory Committee to the Director, an NIH working group says that the agency needs to take steps to combat racial bias in the funding of research grants, reports Science's Michael Price. The group says its goal is to correct what it calls the "disturbing discrepancy" between the number of black applicants winning R01 awards compared to white applicants. The panel is co-chaired by UnitedHealth Group's Reed Tuckson and the NIH Institute on Minority Health and Health Disparities' John Ruffin, Price says.

While the panel has laid out an agenda, it has yet to offer specific recommendations, and has given no estimates of how much such a program might cost, Price says. Tuckson has said it's too soon for such details, as NIH first needs to get together with other agencies to fully support institutions that train minority researchers, Price adds. The panel also recommended that NIH create a new position of chief diversity officer, conduct pilot testing of the NIH review staff's awareness of bias and diversity, and experiment with anonymous reviews, where applicants' identities are blanked out.

The Scan

Booster for At-Risk

The New York Times reports that the US Food and Drug Administration has authorized a third dose of the Pfizer-BioNTech SARS-CoV-2 vaccine for people 65 and older or at increased risk.

Preprints OK to Mention Again

Nature News reports the Australian Research Council has changed its new policy and now allows preprints to be cited in grant applications.

Hundreds of Millions More to Share

The US plans to purchase and donate 500 million additional SARS-CoV-2 vaccine doses, according to the Washington Post.

Nature Papers Examine Molecular Program Differences Influencing Neural Cells, Population History of Polynesia

In Nature this week: changes in molecular program during embryonic development leads to different neural cell types, and more.